Abstract: The object of this invention is to elucidate the factors involved in the regulation of AGE (advanced glycation endproducts, which are produced in a living body accompanied with diabetes and aging) and RAGE (the receptor for AGE), in order to facilitate investigation on the biological activities, physiological phenomenon and diseases related to AGE and RAGE. Plural molecular species are known to exist for RAGE, and among such molecular species, soluble RAGE exhibits the activity to modulate interaction between AGE and transmembrane-type RAGE. Using this soluble RAGE or a nucleic acid encoding it, the soluble RAGE can be measured, in addition, investigation on various physiological phenomenon, biological activities, and diseases related to interaction between AGE and RAGE can be performed to facilitate development a medicine having further efficacy.
Type:
Grant
Filed:
March 19, 2002
Date of Patent:
February 3, 2009
Assignee:
Japan as Represented by President of Kanazawa University
Abstract: There is disclosed a gradient structure material comprising a substrate 1 and a functional material 2 formed on the substrate. The gradient structure material is thermally treated while a desired gradient temperature is applied to a specific direction and a specific region of the functional material on the substrate. Consequently, without adding “gradient structure” of a component concentration, a content of oxide, or a crystal structure, the functional material on the substrate is provided with useful function which is not heretofore existed, or a performance can be enhanced unlike a conventional technique.
Type:
Application
Filed:
January 8, 2004
Publication date:
November 1, 2007
Applicants:
Japan as Represented by President of Kanazawa University, Ihi Aerospace Co., Ltd.
Inventors:
Tomonobu Hata, Kimihiro Sasaki, Shinichi Morita, Kimiko Morita